-
1
-
-
0035065903
-
The treatment of acute leukemia: Past, present, and future
-
Beutler E (2001). The treatment of acute leukemia: past, present, and future. Leukemia, 15: 658-661.
-
(2001)
Leukemia
, vol.15
, pp. 658-661
-
-
Beutler, E.1
-
2
-
-
0034080534
-
Recent advances in management of acute leukemia
-
Chessels JM (2000). Recent advances in management of acute leukemia. Archives of Disease in Childhood, 82: 438-442.
-
(2000)
Archives of Disease in Childhood
, vol.82
, pp. 438-442
-
-
Chessels, J.M.1
-
3
-
-
0030030346
-
Selecting treatment for children with acute lymphoblastic leukemia
-
Pinkel D (1996). Selecting treatment for children with acute lymphoblastic leukemia. Journal of Clinical Oncology, 14: 4-6.
-
(1996)
Journal of Clinical Oncology
, vol.14
, pp. 4-6
-
-
Pinkel, D.1
-
4
-
-
0027383632
-
Non-compliance - Or how many aunts has Matilda?
-
Wright EC (1993). Non-compliance - or how many aunts has Matilda? Lancet, 342: 909-913.
-
(1993)
Lancet
, vol.342
, pp. 909-913
-
-
Wright, E.C.1
-
5
-
-
0023722763
-
Rapid method for evaluating compliance of 6-mercaptopurine therapy in children with leukemia
-
Azeemuddin S & Bharmal FM (1988). Rapid method for evaluating compliance of 6-mercaptopurine therapy in children with leukemia. Journal of Chromatography, 430: 163-169.
-
(1988)
Journal of Chromatography
, vol.430
, pp. 163-169
-
-
Azeemuddin, S.1
Bharmal, F.M.2
-
6
-
-
0026782292
-
Pattern of 6-mercaptopurine urinary excretion in children with acute lymphoblastic leukemia: Urinary assays as a measure of drug compliance
-
MacDougall LG, McElligott SE, Ross E, Greeff MC & Poole JE (1992). Pattern of 6-mercaptopurine urinary excretion in children with acute lymphoblastic leukemia: urinary assays as a measure of drug compliance. Therapeutic Drug Monitoring, 14: 371-375.
-
(1992)
Therapeutic Drug Monitoring
, vol.14
, pp. 371-375
-
-
MacDougall, L.G.1
McElligott, S.E.2
Ross, E.3
Greeff, M.C.4
Poole, J.E.5
-
7
-
-
0027298618
-
Variable mercaptopurine metabolism in children with leukaemia: A problem of non-compliance?
-
Davies HA, Lennard L & Lilleyman JS (1993). Variable mercaptopurine metabolism in children with leukaemia: a problem of non-compliance? British Medical Journal, 306: 1239-1240.
-
(1993)
British Medical Journal
, vol.306
, pp. 1239-1240
-
-
Davies, H.A.1
Lennard, L.2
Lilleyman, J.S.3
-
8
-
-
0028832238
-
Intracellular metabolites of mercaptopurine in children with lymphoblastic leukaemia: A possible indicator of non-compliance?
-
Lennard L, Welch J & Lilleyman JS (1995). Intracellular metabolites of mercaptopurine in children with lymphoblastic leukaemia: a possible indicator of non-compliance? British Journal of Cancer, 72: 1004-1006.
-
(1995)
British Journal of Cancer
, vol.72
, pp. 1004-1006
-
-
Lennard, L.1
Welch, J.2
Lilleyman, J.S.3
-
11
-
-
0029790730
-
Individualizing therapy with 6-mercaptopurine and 6-thioguanine related to the thiopurine methyltransferase genetic polymorphism
-
Lennard L & Lilleyman JS (1996). Individualizing therapy with 6-mercaptopurine and 6-thioguanine related to the thiopurine methyltransferase genetic polymorphism. Therapeutic Drug Monitoring, 18: 328-334.
-
(1996)
Therapeutic Drug Monitoring
, vol.18
, pp. 328-334
-
-
Lennard, L.1
Lilleyman, J.S.2
-
12
-
-
0033027232
-
Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia
-
McLeod HL, Coulthard S, Thomas AE, Pritchard SC, King DJ, Richards SM, Eden OB & Hall AG (1999). Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia. British Journal of Haematology, 105: 696-700.
-
(1999)
British Journal of Haematology
, vol.105
, pp. 696-700
-
-
McLeod, H.L.1
Coulthard, S.2
Thomas, A.E.3
Pritchard, S.C.4
King, D.J.5
Richards, S.M.6
Eden, O.B.7
Hall, A.G.8
-
13
-
-
0032856425
-
The interaction of 6-mercaptopurine (6-MP) and methotrexate (MTX)
-
Giverhaug T, Loennechen T & Aarbakke J (1999). The interaction of 6-mercaptopurine (6-MP) and methotrexate (MTX). General Pharmacology, 33: 341-346.
-
(1999)
General Pharmacology
, vol.33
, pp. 341-346
-
-
Giverhaug, T.1
Loennechen, T.2
Aarbakke, J.3
-
14
-
-
0023119219
-
Thiopurine pharmacogenetics in leukemia: Correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations
-
Lennard L, van Loon JA, Lilleyman JS & Weinshilboum RM (1987). Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations. Clinical Pharmacology and Therapeutics, 41: 18-25.
-
(1987)
Clinical Pharmacology and Therapeutics
, vol.41
, pp. 18-25
-
-
Lennard, L.1
van Loon, J.A.2
Lilleyman, J.S.3
Weinshilboum, R.M.4
-
15
-
-
0025331198
-
Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia
-
Lennard L, Lilleyman JS, Loon JV & Weinshilboum RM (1990). Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia. Lancet, 336: 225-229.
-
(1990)
Lancet
, vol.336
, pp. 225-229
-
-
Lennard, L.1
Lilleyman, J.S.2
Loon, J.V.3
Weinshilboum, R.M.4
-
16
-
-
0028044714
-
Thiopurine methyltransferase activity in American white subjects and black subjects
-
McLeod HL, Lin JS, Scott EP, Pui CH & Evans VVE (1994). Thiopurine methyltransferase activity in American white subjects and black subjects. Clinical Pharmacology and Therapeutics, 55: 15-20.
-
(1994)
Clinical Pharmacology and Therapeutics
, vol.55
, pp. 15-20
-
-
McLeod, H.L.1
Lin, J.S.2
Scott, E.P.3
Pui, C.H.4
Evans, V.V.E.5
-
17
-
-
0018822866
-
Mercaptopurine pharmacogenetics: Monogenic inheritance of erythrocyte thiopurine methyltransferase activity
-
Weinshilboum RM & Sladek SL (1980). Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. American Journal of Human Genetics, 32: 651-662.
-
(1980)
American Journal of Human Genetics
, vol.32
, pp. 651-662
-
-
Weinshilboum, R.M.1
Sladek, S.L.2
-
20
-
-
0032533637
-
Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: A joint children's cancer group and pediatric oncology branch study
-
Balis FM, Holcenberg JS, Poplack DG et al. (1998). Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: A joint children's cancer group and pediatric oncology branch study. Blood, 92: 3569-3577.
-
(1998)
Blood
, vol.92
, pp. 3569-3577
-
-
Balis, F.M.1
Holcenberg, J.S.2
Poplack, D.G.3
-
21
-
-
0025195675
-
6-Thioguanine nucleotide accumulation in red blood cells during maintenance chemotherapy for childhood acute lymphoblastic leukemia, and it relation to leukopenia
-
Schmiegelow K & Bruunshuus I (1990). 6-Thioguanine nucleotide accumulation in red blood cells during maintenance chemotherapy for childhood acute lymphoblastic leukemia, and it relation to leukopenia. Cancer Chemotherapy and Pharmacology, 26: 288-292.
-
(1990)
Cancer Chemotherapy and Pharmacology
, vol.26
, pp. 288-292
-
-
Schmiegelow, K.1
Bruunshuus, I.2
-
22
-
-
0027524983
-
Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia
-
Lennard L, Gibson BES, Nicole T & Lilleyman JS (1993). Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia. Archives of Disease in Childhood, 69: 577-579.
-
(1993)
Archives of Disease in Childhood
, vol.69
, pp. 577-579
-
-
Lennard, L.1
Gibson, B.E.S.2
Nicole, T.3
Lilleyman, J.S.4
-
23
-
-
0028860142
-
Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance therapy
-
Schmiegelow K, Schroder H, Gustafsson G, Kristinsson J, Glomstein A, Salmi T & Wranne L (1995). Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance therapy. Journal of Clinical Oncology, 13: 345-351.
-
(1995)
Journal of Clinical Oncology
, vol.13
, pp. 345-351
-
-
Schmiegelow, K.1
Schroder, H.2
Gustafsson, G.3
Kristinsson, J.4
Glomstein, A.5
Salmi, T.6
Wranne, L.7
-
24
-
-
0033867006
-
Variable correlation between 6-mercaptopurine metabolites in erythrocytes and hematologic toxicity: Implications for drug monitoring in children with acute lymphoblastic leukemia
-
Innocenti F, Danesi R, Favre C et al. (2000). Variable correlation between 6-mercaptopurine metabolites in erythrocytes and hematologic toxicity: Implications for drug monitoring in children with acute lymphoblastic leukemia. Therapeutic Drug Monitoring, 22: 375-382.
-
(2000)
Therapeutic Drug Monitoring
, vol.22
, pp. 375-382
-
-
Innocenti, F.1
Danesi, R.2
Favre, C.3
-
25
-
-
0031648054
-
Identification of 6- methylmercaptopurine derivative formed during acid hydrolysis of thiopurine nucleotides in erythrocytes, using liquid chromatography-mass spectrometry, infrared spectroscopy, and nuclear magnetic resonance assay
-
Dervieux T & Boulieu R (1998). Identification of 6- methylmercaptopurine derivative formed during acid hydrolysis of thiopurine nucleotides in erythrocytes, using liquid chromatography-mass spectrometry, infrared spectroscopy, and nuclear magnetic resonance assay. Clinical Chemistry, 44: 2511-2515.
-
(1998)
Clinical Chemistry
, vol.44
, pp. 2511-2515
-
-
Dervieux, T.1
Boulieu, R.2
-
26
-
-
0026465403
-
High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: Quantification of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample
-
Lennard L & Singleton HJ (1992). High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: quantification of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample. Journal of Chromatography, 583: 83-90.
-
(1992)
Journal of Chromatography
, vol.583
, pp. 83-90
-
-
Lennard, L.1
Singleton, H.J.2
-
27
-
-
0031889642
-
Simultaneous determination of 6-thioguanine and methyl 6-mercaptopurine nucleotides of azathioprine in red blood cells by HPLC
-
Dervieux T & Boulieu R (1998). Simultaneous determination of 6-thioguanine and methyl 6-mercaptopurine nucleotides of azathioprine in red blood cells by HPLC. Clinical Chemistry, 44: 551-555.
-
(1998)
Clinical Chemistry
, vol.44
, pp. 551-555
-
-
Dervieux, T.1
Boulieu, R.2
-
28
-
-
0023588197
-
Assay of 6-thioinosinic acid and 6-thioguanine nucleotides, active metabolites of 6-mercaptopurine, in human red blood cells
-
Lennard L (1987). Assay of 6-thioinosinic acid and 6-thioguanine nucleotides, active metabolites of 6-mercaptopurine, in human red blood cells. Journal of Chromatography, 423: 169-178.
-
(1987)
Journal of Chromatography
, vol.423
, pp. 169-178
-
-
Lennard, L.1
-
30
-
-
0026079420
-
Determination of 6-mercaptopurine in acute lymphoblastic leukemia patients' plasma by high performance liquid chromatography
-
Kato Y, Matsushita T, Yokoyama T & Mohri K (1991). Determination of 6-mercaptopurine in acute lymphoblastic leukemia patients' plasma by high performance liquid chromatography. Therapeutic Drug Monitoring, 13: 220-225.
-
(1991)
Therapeutic Drug Monitoring
, vol.13
, pp. 220-225
-
-
Kato, Y.1
Matsushita, T.2
Yokoyama, T.3
Mohri, K.4
-
32
-
-
0029065545
-
Compliance with oral chemotherapy in childhood lymphoblastic leukaemia
-
Davies HA & Lilleyman JS (1995). Compliance with oral chemotherapy in childhood lymphoblastic leukaemia. Cancer Treatment Reviews, 21: 93-103.
-
(1995)
Cancer Treatment Reviews
, vol.21
, pp. 93-103
-
-
Davies, H.A.1
Lilleyman, J.S.2
-
33
-
-
0031473742
-
Analysis of methylated 6-mercaptopurine metabolites in human red blood cells: Comparison of two methods
-
Giverhaug T, Bergan S, Loennechen T, Rugstad HE & Aarbakke J (1997). Analysis of methylated 6-mercaptopurine metabolites in human red blood cells: Comparison of two methods. Therapeutic Drug Monitoring, 19: 663-668.
-
(1997)
Therapeutic Drug Monitoring
, vol.19
, pp. 663-668
-
-
Giverhaug, T.1
Bergan, S.2
Loennechen, T.3
Rugstad, H.E.4
Aarbakke, J.5
-
34
-
-
0032566771
-
Reversed-phase high-perfomance liquid chromatographic assay method for quantitating 6-mercaptopurine and its methylated and non-methylated metabolites in a single sample
-
Mawatari H, Kato Y, Nishimura S-I, Sakura N & Ueda K (1998). Reversed-phase high-perfomance liquid chromatographic assay method for quantitating 6-mercaptopurine and its methylated and non-methylated metabolites in a single sample. Journal of Chromatography, 716: 392-396.
-
(1998)
Journal of Chromatography
, vol.716
, pp. 392-396
-
-
Mawatari, H.1
Kato, Y.2
Nishimura, S.-I.3
Sakura, N.4
Ueda, K.5
-
35
-
-
0025148411
-
A reversed phase high performance liquid chromatography approach in determining total red blood cell concentrations of 6-thioguanine, 6-mercaptopurine, methylthioguanine, and methylmercaptopurine in patient receiving thiopurine therapy
-
Erdmann GR, France LA, Bostrom B & Canafax DM (1990). A reversed phase high performance liquid chromatography approach in determining total red blood cell concentrations of 6-thioguanine, 6-mercaptopurine, methylthioguanine, and methylmercaptopurine in patient receiving thiopurine therapy. Biomedical Chromatography, 4: 47-51.
-
(1990)
Biomedical Chromatography
, vol.4
, pp. 47-51
-
-
Erdmann, G.R.1
France, L.A.2
Bostrom, B.3
Canafax, D.M.4
-
36
-
-
0033486029
-
Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus
-
Relling MV, Hancock ML, Rivera GK, Sandlund JT, Ribeiro RC, Krynetski EY, Pui C-H & Evans WE (1999). Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus. Journal of the National Cancer Institute, 91: 2001-2008.
-
(1999)
Journal of the National Cancer Institute
, vol.91
, pp. 2001-2008
-
-
Relling, M.V.1
Hancock, M.L.2
Rivera, G.K.3
Sandlund, J.T.4
Ribeiro, R.C.5
Krynetski, E.Y.6
Pui, C.-H.7
Evans, W.E.8
-
37
-
-
0034034158
-
Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia
-
McLeod HL, Krynetski EY, Relling MV & Evans WE (2000). Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia, Leukemia, 14: 567-572.
-
(2000)
Leukemia
, vol.14
, pp. 567-572
-
-
McLeod, H.L.1
Krynetski, E.Y.2
Relling, M.V.3
Evans, W.E.4
|